Publication:
Celexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial

Simple item page
dc.contributor.authorsYazici, H; Ozdemir, O; Kirazli, Y; Ozbek, S; Ozerbil, O; Gur, A; Ardicoglu, O; Seyahi, E; Akarirmak, U; Sepici, V; Uysal, FG; Ertenli, I; Inal, V; Kayhan, O; Kuru, O; Gilgil, E; Bingol, U; Aksoy, C; Ergin, S; Cetin, A; Tan, K; Aral, O
dc.date.accessioned2022-03-12T15:59:01Z
dc.date.accessioned2026-01-10T18:05:34Z
dc.date.available2022-03-12T15:59:01Z
dc.date.issued2003
dc.identifier.doidoiWOS:000224551400849
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/224255
dc.identifier.wosWOS:000224551400849
dc.language.isoeng
dc.publisherB M J PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleCelexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage260
oaire.citation.startPage260
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume62

Files

Collections

Araştırma Çıktıları